Vantage logo

The lung fibrosis pipeline thins

This month Pliant Therapeutics claimed a win in idiopathic pulmonary fibrosis, but other projects have fallen by the wayside.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.